A randomised controlled trial in which women discharged from the symptomatic breast clinic, who are above population risk (according to Tyrer Cuzick) will be asked to create lifestyle related goals. They will be told their estimated risk of developing breast cancer and will be randomised to one of three interventions: * Breast cancer risk leaflet only * lifestyle website * lifestyle website plus group coaching. Fifty per cent of women will also be randomised to have Single Nucleotide Polymorphisms (SNPs) performed, and these will be incorporated into their risk score. The primary end point will be whether or not women achieve their lifestyle goal.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
240
Women will be educated about lifestyle factors which increase breast cancer risk. They will also be guided through an online goal setting process.
The Royal Marsden Hospital NHS Foundation Trust
Sutton, United Kingdom
Goal achievement
Whether women have achieved their lifestyle goals. Proportion answering "yes" to a binary question: Did you achieve the goal you set? Compared between the three arms.
Time frame: Women will be asked this 12 months after entering the study
To assess the acceptability of women to find out their personalised breast cancer risk and to commit to making a change in a modifiable risk factor
Proportion of women approached who go on to join the study
Time frame: Measured when recruitment is complete, estimated at 3 months from start date
To assess the acceptability of randomisation to different arms of intervention
Attrition rate after randomisation within each group
Time frame: Measured when the final participant has completed 12 months in the study, estimated 15 months from start date
To assess the impact of SNP testing on changes in behavioural risk factors
Goal achievement in SNP group compared with goal achievement in non-SNP group.
Time frame: Measured when the final participant has completed 12 months in the study estimated 15 months from start date
To assess the impact of the different interventions on changes in behavioural risk factors
Goal achievement compared between leaflet only group, website group and website + coaching group.
Time frame: Measured when the final participant has completed 12 months in the study estimated 15 months from start date
To assess the impact of knowledge of breast cancer risk on cancer anxiety scores
Change in Cancer Worry Scale (Revised) score from 0 to 3 months. Cancer Worry score is measured between 8 and 32 with 32 being the highest level of anxiety.
Time frame: Measured when the final participant has completed 12 months in the study estimated 15 months from start date
To identify whether there is an association between initial Cancer Worry Scale (Revised) score and change in behavioural risk factors
Cancer Worry score compared with goal achievement. Cancer Worry score is between 8 and 32 with 32 being the highest level of anxiety.
Time frame: Measured when the final participant has completed 12 months in the study estimated 15 months from start date
To identify whether commitment to a study of this design is sustainable and affected by study group
Participant retention rate.
Time frame: Measured when the final participant has completed 12 months in the study estimated 15 months from start date
To assess the impact of the different interventions on uptake and adherence to chemoprevention at 1 year
Proportion of women still taking chemoprevention at close of study compared between the three arms.
Time frame: Measured when the final participant has completed 12 months in the study estimated 15 months from start date
To consider the scalability of each element of the pilot study
Administration time required for each group; Average goal achievement compared to average cost of each intervention.
Time frame: Measured when the final participant has completed 12 months in the study estimated 15 months from start date
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.